UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level

Clinical pharmacology and therapeutics, 2022-03, Vol.111 (3), p.605-613

2022

Volltextzugriff (PDF)

Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT)

British journal of clinical pharmacology, 2023-01, Vol.89 (1), p.390-400

2023

Volltextzugriff (PDF)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)

Therapie, 2023-09, Vol.78 (5), p.499-507

2023

Volltextzugriff (PDF)

Ophthalmic adverse events under tofacitinib and baricitinib: Case analysis of the European Pharmacovigilance Database

Joint, bone, spine : revue du rhumatisme, 2023-01, Vol.90 (1), p.105483-105483, Article 105483

2023

Volltextzugriff (PDF)

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring

Blood, 2022-04, Vol.139 (16), p.2561-2565

2022

Volltextzugriff (PDF)

COVID-19 vaccines surveillance in France: a global response to a major national challenge

Anaesthesia critical care & pain medicine, 2021-06, Vol.40 (3), p.100866-100866, Article 100866

2021

Volltextzugriff (PDF)

Risk of scleroderma according to the type of immune checkpoint inhibitors

Autoimmunity reviews, 2020-08, Vol.19 (8), p.102596, Article 102596

2020

Volltextzugriff (PDF)

REview of potentially inappropriate MEDIcation pr[e]scribing in Seniors (REMEDI[e]S): French implicit and explicit criteria

European journal of clinical pharmacology, 2021-11, Vol.77 (11), p.1713-1724

2021

Volltextzugriff (PDF)

Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment

Vaccines (Basel), 2024-02, Vol.12 (2), p.181

2024

Volltextzugriff (PDF)

Roxadustat, an hypoxia-inducible factor-prolyl hydroxylase inhibitor induce sickle cell crisis: A case report

British journal of haematology, 2024-09

2024

Volltextzugriff (PDF)

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

JMIR public health and surveillance, 2023-07, Vol.9, p.e45263-e45263

2023

Volltextzugriff (PDF)

Economic burden of hospital admissions for adverse drug reactions in France: The IATROSTAT-ECO study

British journal of clinical pharmacology, 2024-10

2024

Volltextzugriff (PDF)

Ocular Safety Profile of BRAF and MEK Inhibitors: Data from the World Health Organization Pharmacovigilance Database

Ophthalmology (Rochester, Minn.), 2021-12, Vol.128 (12), p.1748-1755

2021

Volltextzugriff (PDF)

c‐Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome

British journal of haematology, 2005-03, Vol.128 (6), p.767-773

2005

Volltextzugriff (PDF)

Epidemiology and economic burden of “serious” adverse drug reactions: Real-world evidence research based on pharmacovigilance data

Therapie, 2022-05, Vol.77 (3), p.291-300

2022

Volltextzugriff (PDF)

Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases

British journal of clinical pharmacology, 2019-03, Vol.85 (3), p.570-579

2019

Volltextzugriff (PDF)

Are clinical data from spontaneous pharmacovigilance reports transmitted via the Ministry of Health's web portal sufficient to generate a signal without further documentation?

Therapie, 2024-07, Vol.79 (4), p.493-496

2024

Volltextzugriff (PDF)

Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012

Allergy (Copenhagen), 2018-11, Vol.73 (11), p.2224-2233

2018

Volltextzugriff (PDF)

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge

Therapie, 2021-07, Vol.76 (4), p.297-303

2021

Volltextzugriff (PDF)

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease

Clinical Medicine Insights. Oncology, 2015-01, Vol.2015 (9), p.75-79

2015

Volltextzugriff (PDF)

Leukocytosis during pirfenidone therapy: A case report

Therapie, 2018-12, Vol.73 (6), p.541-543

2018

Volltextzugriff (PDF)

Acceptability and effectiveness of immunotherapy in patients with melanoma

Therapie, 2019-06, Vol.74 (3), p.355

2019

Volltextzugriff (PDF)

Mapping of drug-related problems among older adults conciliating medical and pharmaceutical approaches

European geriatric medicine, 2021-06, Vol.12 (3), p.485-497

2021

Volltextzugriff (PDF)

Updating the French Method for the Causality Assessment of Adverse Drug Reactions

Therapie, 2013-03, Vol.68 (2), p.69-76

2013

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(39)
Französisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Pharmacovigilance
(27)
Humans
(24)
Pharmacology & Pharmacy
(24)
Female
(14)
Life Sciences
(14)
Male
(14)
Middle Aged
(13)
Aged
(11)
Adult
(9)
Adverse Drug Reaction
(8)
Drug Safety
(7)
France - Epidemiology
(7)
France
(6)
Retrospective Studies
(6)
Vaccines
(6)
Adverse Drug Reaction Reporting Systems
(5)
Covid-19
(5)
Covid-19 - Prevention & Control
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level

Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)

Ophthalmic adverse events under tofacitinib and baricitinib: Case analysis of the European Pharmacovigilance Database

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring

COVID-19 vaccines surveillance in France: a global response to a major national challenge

Risk of scleroderma according to the type of immune checkpoint inhibitors

REview of potentially inappropriate MEDIcation pr[e]scribing in Seniors (REMEDI[e]S): French implicit and explicit criteria

Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment

Roxadustat, an hypoxia-inducible factor-prolyl hydroxylase inhibitor induce sickle cell crisis: A case report

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Economic burden of hospital admissions for adverse drug reactions in France: The IATROSTAT-ECO study

Ocular Safety Profile of BRAF and MEK Inhibitors: Data from the World Health Organization Pharmacovigilance Database

c‐Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome

Epidemiology and economic burden of “serious” adverse drug reactions: Real-world evidence research based on pharmacovigilance data

Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases

Are clinical data from spontaneous pharmacovigilance reports transmitted via the Ministry of Health's web portal sufficient to generate a signal without further documentation?

Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease

Leukocytosis during pirfenidone therapy: A case report

Acceptability and effectiveness of immunotherapy in patients with melanoma

Mapping of drug-related problems among older adults conciliating medical and pharmaceutical approaches

Updating the French Method for the Causality Assessment of Adverse Drug Reactions

Suchergebnisse filtern